STOK

Stoke Therapeutics
STOK

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.65B
EV
$1.29B
Shares Outstanding
59.66M
Beta
1.14
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
9
P/E 2025E
114.29x
P/Revenue 2025E
8.87x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Stoke Therapeutics, Inc.

gainify
STOK

Stoke Therapeutics, Inc.

STOK

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary targeted augmentation of nuclear gene output to develop antisens...

Sector

Healthcare

Industry

Biotechnology

CEO

Kaye, Edward

Employees

128

IPO Date

2019-06-19

Headquarters

45 Wiggins Avenue, Bedford, Massachusetts, 01730, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.